Serina Therapeutics, Inc. (SER) Operating income 2017–2025
Serina Therapeutics, Inc. (SER) annual operating income history from SEC filings — each fiscal year as reported.
-$24.0MFY2025 · since FY2017: -$6.7M → -$24.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$24.0M | -40.9% |
| FY2024 | -$17.0M | -444.8% |
| FY2023 | -$3.1M | +55.1% |
| FY2022 | -$7.0M | +12.1% |
| FY2021 | -$7.9M | +21.5% |
| FY2020 | -$10.1M | +19.6% |
| FY2019 | -$12.6M | -11.7% |
| FY2018 | -$11.2M | -68.8% |
| FY2017 | -$6.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice